The kidney in diabetes: dynamic pathways of injury and repair. The Camillo Golgi Lecture 2007
- PMID: 18528679
- DOI: 10.1007/s00125-008-1051-7
The kidney in diabetes: dynamic pathways of injury and repair. The Camillo Golgi Lecture 2007
Abstract
Diabetic nephropathy is the most common cause of end-stage renal disease (ESRD). The natural history of diabetic nephropathy has changed over the last decades, as a consequence of better metabolic and blood pressure management. Thus, it may now be possible to delay or halt the progression towards ESRD in patients with overt diabetic nephropathy, and the decline of renal function is not always inexorable and unavoidable. Also, the rate of progression from microalbuminuria to overt nephropathy is much lower than originally estimated in the early 80s. Furthermore, there is now evidence that it is possible, in humans, to obtain reversal of the established lesions of diabetic nephropathy. This review focuses on the contribution of kidney biopsy studies to the understanding of the pathogenesis and natural history of diabetic nephropathy and the identification of patients at high risk of progression to ESRD. The classic lesions of diabetic nephropathy and the well-established structural-functional relationships in type 1 diabetes will be briefly summarised and the renal lesions leading to renal dysfunction in type 2 diabetes will be described. The relevance of these biopsy studies to diabetic nephropathy pathogenesis will be outlined. Finally, the evidence and the possible significance of reversibility of diabetic renal lesions will be discussed, as well as future directions for research in this field.
Similar articles
-
Lessons learned from studies of the natural history of diabetic nephropathy in young type 1 diabetic patients.Pediatr Endocrinol Rev. 2008 Aug;5 Suppl 4:958-63. Pediatr Endocrinol Rev. 2008. PMID: 18806710 Review.
-
Glomerular basement membrane duplication is a predictor of the prognosis of diabetic nephropathy in patients with type 2 diabetes.Clin Exp Nephrol. 2019 Apr;23(4):521-529. doi: 10.1007/s10157-018-1674-z. Epub 2018 Nov 22. Clin Exp Nephrol. 2019. PMID: 30467801
-
Renal lesions predict progression of diabetic nephropathy in type 1 diabetes.J Am Soc Nephrol. 2013 Jun;24(7):1175-81. doi: 10.1681/ASN.2012070739. Epub 2013 May 16. J Am Soc Nephrol. 2013. PMID: 23687360 Free PMC article.
-
Structural involvement in type 1 and type 2 diabetic nephropathy.Diabetes Metab. 2000 Jul;26 Suppl 4:8-14. Diabetes Metab. 2000. PMID: 10922968 Review.
-
Temporal profile of diabetic nephropathy pathologic changes.Curr Diab Rep. 2013 Aug;13(4):592-9. doi: 10.1007/s11892-013-0395-7. Curr Diab Rep. 2013. PMID: 23712652 Review.
Cited by
-
Sulodexide decreases albuminuria and regulates matrix protein accumulation in C57BL/6 mice with streptozotocin-induced type I diabetic nephropathy.PLoS One. 2013;8(1):e54501. doi: 10.1371/journal.pone.0054501. Epub 2013 Jan 22. PLoS One. 2013. PMID: 23349910 Free PMC article.
-
Trajectories of kidney function in diabetes: a clinicopathological update.Nat Rev Nephrol. 2021 Nov;17(11):740-750. doi: 10.1038/s41581-021-00462-y. Epub 2021 Aug 6. Nat Rev Nephrol. 2021. PMID: 34363037 Review.
-
Classification and Differential Diagnosis of Diabetic Nephropathy.J Diabetes Res. 2017;2017:8637138. doi: 10.1155/2017/8637138. Epub 2017 Feb 20. J Diabetes Res. 2017. PMID: 28316995 Free PMC article. Review.
-
Hyperinsulinemia Can Cause Kidney Disease in the IGT Stage of OLETF Rats via the INS/IRS-1/PI3-K/Akt Signaling Pathway.J Diabetes Res. 2019 Oct 13;2019:4709715. doi: 10.1155/2019/4709715. eCollection 2019. J Diabetes Res. 2019. PMID: 31737684 Free PMC article.
-
L-NAME Administration Enhances Diabetic Kidney Disease Development in an STZ/NAD Rat Model.Int J Mol Sci. 2021 Nov 25;22(23):12767. doi: 10.3390/ijms222312767. Int J Mol Sci. 2021. PMID: 34884571 Free PMC article.
References
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical